Timber Pharmaceuticals Overview

Timber Pharmaceuticals EBIT

EBIT (Earnings Before Interest and Taxes) analysis for TMBR.

Quarterly EBIT

-$3.83M

↑ 59.3% YoY

As of Jun 30, 2023

Annual EBIT (TTM)

-$14.52M

↑ 20.87% YoY

Trailing 12 months ending Jun 30, 2023

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin